Influence of brachytherapy applicators geometry on dose distribution in cervical cancer

Although the relationship between the dose delivered to adjacent organs (urinary bladder and rectum) and the frequency and severity of treatment complications has been reported in many series, the factors influencing pelvic dose distribution are not well defined. The aim of the study was to assess r...

Full description

Saved in:
Bibliographic Details
Published in:Strahlentherapie und Onkologie Vol. 173; no. 6; pp. 323 - 329
Main Authors: SENKUS-KONEFKA, E, KOBIERSKA, A, JASSEM, J, SERKIES, K, BADZIO, A
Format: Journal Article
Language:English
Published: München Springer 01-06-1997
Springer Nature B.V
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Although the relationship between the dose delivered to adjacent organs (urinary bladder and rectum) and the frequency and severity of treatment complications has been reported in many series, the factors influencing pelvic dose distribution are not well defined. The aim of the study was to assess retrospectively the influence of the size of cervical cancer brachytherapy applicators (ovoids and uterine tandems) on pelvic dose distribution and the impact of various therapy-dependent factors on patient anatomy and on dose distribution in particular applications. The subject of this study were 356 cervical cancer patients treated with Selectron LDR as a part of their radical radiotherapy. Analysed factors included preceding external beam radiotherapy (EBRT) or brachytherapy applications, use of general anaesthesia for application and the system of pellet loading. Significant correlation was found between the size of applicators and doses to bladder, rectum and points B: larger vaginal applicators produced lower dose in bladder and rectum and higher dose in point B (all p < 0.0001), longer uterine tandems produced lower dose in rectum and higher dose in point B (both p < 0.0001). Significant decrease in the frequency of use of large applicators (ovoids: p < 0.0001, tandems: p = 0.055) and worsening of dose distribution, i.e. higher doses to critical organs (respectively: bladder p = 0.0012, rectum p = 0.02) and lower point B dose (p = 0.0001) were observed at consecutive brachytherapy applications. Similar situation occurred in patients, who received EBRT prior to brachytherapy (ovoids: p < 0.001, tandem: p = 0.04, bladder dose: p = 0.009, rectal dose: p = 0.073, point B dose: p = 0.059). Vaginal applicators were larger (p = 0.026) and the dose distribution was better (bladder: p = 0.023, rectum: p = 0.002, point B: p = 0.0001) in patients who had their insertions performed under general anaesthesia. The comparison of 2 consecutively used systems of pellet loading revealed more favourable dose distribution: lower dose for bladder (p = 0.014) and higher dose for point B (p < 0.0001) for the system, which utilised more sources in ovoids and in the distal part of the uterine tandem, in spite of more frequent use of smaller applicators in this group of patients. In multivariate analysis ovoid size was related to preceding external beam radiotherapy (p = 0.025). Uterine tandem length was dependent on the number of preceding intracavitary applications (p < 0.001) and preceding external beam radiotherapy (p = 0.007). Bladder dose was related to preceding brachytherapy (p = 0.011) and the pattern of pellet loading (p = 0.031). Rectal dose was dependent only on the use of general anaesthesia during application (p = 0.001) and point B dose was dependent on the pattern of pellet loading (p < 0.001) and marginally-on the use of preceding external beam radiotherapy (p = 0.06). The results of this study allow for identification of treatment-related factors determining pelvic dose distribution in cervical cancer brachytherapy and may potentially enable optimisation of this distribution in particular clinical situation.
AbstractList AimAlthough the relationship between the dose delivered to adjacent organs (urinary bladder and rectum) and the frequency and severity of treatment complications has been reported in many series, the factors influencing pelvic dose distribution are not well defined. The aim of the study was to assess retrospectively the influence of the size of cervical cancer brachytherapy applicators (ovoids and uterine tandems) on pelvic dose distribution and the impact of various therapy-dependent factors on patient anatomy and on dose distribution in particular applications.Patients and MethodThe subject of this study were 356 cervical cancer patients treated with Selectron LDR as a part of their radical radiotherapy. Analysed factors included preceding external beam radiotherapy (EBRT) or brachytherapy applications, use of general anaesthesia for application and the system of pellet loading.ResultsSignificant correlation was found between the size of applicators and doses to bladder, rectum and points B: larger vaginal applicators produced lower dose in bladder and rectum and higher dose in point B (all p<0.0001), longer uterine tandems produced lower dose in rectum and higher dose in point B (both p<0.0001). Significant decrease in the frequency of use of large applicators (ovoids: p<0.0001, tandems: p=0.055) and worsening of dose distribution, i.e. higher doses to critical organs (respectively: bladder p=0.0012, rectum p=0.02) and lower point B dose (p=0.0001) were observed at consecutive brachytherapy applications. Similar situation occurred in patients, who received EBRT prior to brachytherapy (ovoids: p<0.001, tandem: p=0.04, bladder dose: p=0.009, rectal dose: p=0.073, point B dose: p=0.059). Vaginal applicators were larger (p=0.026) and the dose distribution was better (bladder: p=0.023, rectum: p=0.002, point B: p=0.0001) in patients who had their insertions performed under general anaesthesia. The comparison of 2 consecutively used systems of pellet loading revealed more favourable dose distribution: lower dose for bladder (p=0.014) and higher dose for point B (p<0.0001) for the system, which utilised more sources in ovoids and in the distal part of the uterine tandem, in spite of more frequent use of smaller applicators in this group of patients. In multivariate analysis ovoid size was related to preceding external beam radiotherapy (p=0.025). Uterine tandem length was dependent on the number of preceding intracavitary applications (p<0.001) and preceding external beam radiotherapy (p=0.007). Bladder dose was related to preceding brachytherapy (p=0.011) and the pattern of pellet loading (p=0.031). Rectal dose was dependent only on the use of general anaesthesia during application (p=0.001) and point B dose was dependent on the pattern of pellet loading (p<0.001) and marginally — on the use of preceding external beam radiotherapy (p=0.06).ConclusionsThe results of this study allow for identification of treatment-related factors determining pelvic dose distribution in cervical cancer brachytherapy and may potentially enable optimisation of this distribution in particular clinical situation.
Although the relationship between the dose delivered to adjacent organs (urinary bladder and rectum) and the frequency and severity of treatment complications has been reported in many series, the factors influencing pelvic dose distribution are not well defined. The aim of the study was to assess retrospectively the influence of the size of cervical cancer brachytherapy applicators (ovoids and uterine tandems) on pelvic dose distribution and the impact of various therapy-dependent factors on patient anatomy and on dose distribution in particular applications. The subject of this study were 356 cervical cancer patients treated with Selectron LDR as a part of their radical radiotherapy. Analysed factors included preceding external beam radiotherapy (EBRT) or brachytherapy applications, use of general anaesthesia for application and the system of pellet loading. Significant correlation was found between the size of applicators and doses to bladder, rectum and points B: larger vaginal applicators produced lower dose in bladder and rectum and higher dose in point B (all p < 0.0001), longer uterine tandems produced lower dose in rectum and higher dose in point B (both p < 0.0001). Significant decrease in the frequency of use of large applicators (ovoids: p < 0.0001, tandems: p = 0.055) and worsening of dose distribution, i.e. higher doses to critical organs (respectively: bladder p = 0.0012, rectum p = 0.02) and lower point B dose (p = 0.0001) were observed at consecutive brachytherapy applications. Similar situation occurred in patients, who received EBRT prior to brachytherapy (ovoids: p < 0.001, tandem: p = 0.04, bladder dose: p = 0.009, rectal dose: p = 0.073, point B dose: p = 0.059). Vaginal applicators were larger (p = 0.026) and the dose distribution was better (bladder: p = 0.023, rectum: p = 0.002, point B: p = 0.0001) in patients who had their insertions performed under general anaesthesia. The comparison of 2 consecutively used systems of pellet loading revealed more favourable dose distribution: lower dose for bladder (p = 0.014) and higher dose for point B (p < 0.0001) for the system, which utilised more sources in ovoids and in the distal part of the uterine tandem, in spite of more frequent use of smaller applicators in this group of patients. In multivariate analysis ovoid size was related to preceding external beam radiotherapy (p = 0.025). Uterine tandem length was dependent on the number of preceding intracavitary applications (p < 0.001) and preceding external beam radiotherapy (p = 0.007). Bladder dose was related to preceding brachytherapy (p = 0.011) and the pattern of pellet loading (p = 0.031). Rectal dose was dependent only on the use of general anaesthesia during application (p = 0.001) and point B dose was dependent on the pattern of pellet loading (p < 0.001) and marginally-on the use of preceding external beam radiotherapy (p = 0.06). The results of this study allow for identification of treatment-related factors determining pelvic dose distribution in cervical cancer brachytherapy and may potentially enable optimisation of this distribution in particular clinical situation.
ArticleNumber 323
Author SERKIES, K
SENKUS-KONEFKA, E
BADZIO, A
JASSEM, J
KOBIERSKA, A
Author_xml – sequence: 1
  givenname: E
  surname: SENKUS-KONEFKA
  fullname: SENKUS-KONEFKA, E
  organization: Department of Oncology and Radiotherapy, Medical University of Gdańsk, Poland
– sequence: 2
  givenname: A
  surname: KOBIERSKA
  fullname: KOBIERSKA, A
  organization: Department of Oncology and Radiotherapy, Medical University of Gdańsk, Poland
– sequence: 3
  givenname: J
  surname: JASSEM
  fullname: JASSEM, J
  organization: Department of Oncology and Radiotherapy, Medical University of Gdańsk, Poland
– sequence: 4
  givenname: K
  surname: SERKIES
  fullname: SERKIES, K
  organization: Department of Oncology and Radiotherapy, Medical University of Gdańsk, Poland
– sequence: 5
  givenname: A
  surname: BADZIO
  fullname: BADZIO, A
  organization: Department of Oncology and Radiotherapy, Medical University of Gdańsk, Poland
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2701826$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/9209530$$D View this record in MEDLINE/PubMed
BookMark eNpdkEFLHTEUhUOx6NN2030hiLgQxt6bTCbJshW1gtCNpd0NecmdOjJvMiYzhffvjfhQcHXhnI_D5Ttke2McibEvCOcIoL_9uAIJ0lhUH9gKa2krsPbvHlsBaltpVOaAHeb8AIBNbet9tm8FWCVhxf7cjN2w0OiJx46vk_P32_mekpu23E3T0Hs3x5T5P4obmtOWx5GHmImHPs-pXy9zX5J-5J7S_wIP3Lsylj6xj50bMn3e3SP2--ry7uJndfvr-ubi-23lhZJzJZXwNToTpAmd9nVnkRpvQKkATnqLUoMQRNIZrUODqoSGDIagTON9I4_Y6cvulOLjQnluN332NAxupLjkVltEoZUt4PE78CEuaSy_tUagbiTWUKCzF8inmHOirp1Sv3Fp2yK0z6rbN9UF_rpbXNYbCq_ozm3pT3a9y0VMl4qYPr9iQgMa0cgnWMeHDg
CODEN STONE4
CitedBy_id crossref_primary_10_1016_j_ijrobp_2003_09_090
crossref_primary_10_1017_S1460396924000074
crossref_primary_10_1016_j_meddos_2013_06_001
crossref_primary_10_1016_j_brachy_2009_08_014
crossref_primary_10_1120_jacmp_v17i3_5536
crossref_primary_10_1097_00001703_199810000_00011
crossref_primary_10_1120_jacmp_v17i3_5584
Cites_doi 10.1259/0007-1285-49-581-430
10.1016/0090-8258(76)90034-2
10.1016/0360-3016(90)90424-I
10.1016/0360-3016(89)90015-1
10.1259/0007-1285-26-305-252
10.1016/0360-3016(90)90329-I
10.1002/1097-0142(19810715)48:1+<538::AID-CNCR2820481317>3.0.CO;2-P
10.1016/S0002-9378(16)34236-3
10.1016/0167-8140(94)91126-6
10.1016/0360-3016(93)90022-N
10.1016/0360-3016(87)90041-1
10.1016/0360-3016(83)90298-5
10.1148/86.5.921
10.1016/0090-8258(88)90140-0
10.1259/0007-1285-56-666-409
10.1016/0360-3016(82)90446-1
10.1259/0007-1285-60-713-481
10.1259/0007-1285-62-736-362
10.1016/0360-3016(81)90150-4
10.1016/S0009-9260(85)80095-7
10.1016/0360-3016(86)90413-X
10.1016/0360-3016(81)90381-3
10.1016/0360-3016(93)90402-H
10.1016/S0167-8140(87)80182-2
10.1016/0360-3016(87)90193-3
ContentType Journal Article
Copyright 1997 INIST-CNRS
Urban & Vogel 1997.
Copyright_xml – notice: 1997 INIST-CNRS
– notice: Urban & Vogel 1997.
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7RV
7X7
7XB
88E
8AO
8C1
8FE
8FG
8FI
8FJ
8FK
ABUWG
AFKRA
ARAPS
BENPR
BGLVJ
CCPQU
DWQXO
FYUFA
GHDGH
HCIFZ
K9.
KB0
M0S
M1P
NAPCQ
P5Z
P62
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1007/BF03038915
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
ProQuest Nursing and Allied Health Journals
Health Medical collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
ProQuest SciTech Collection
ProQuest Technology Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
Advanced Technologies & Aerospace Database‎ (1962 - current)
ProQuest Central
Technology Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
SciTech Premium Collection (Proquest) (PQ_SDU_P3)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Nursing & Allied Health Premium
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Technology Collection
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Medical Library (Alumni)
Advanced Technologies & Aerospace Collection
ProQuest Public Health
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Advanced Technologies & Aerospace Database
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Technology Collection
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1439-099X
EndPage 329
ExternalDocumentID 2226114921
10_1007_BF03038915
9209530
2701826
Genre Journal Article
Comparative Study
GroupedDBID ---
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.VR
04C
06C
06D
0R~
0VY
123
1N0
1SB
203
29Q
29~
2J2
2JN
2JY
2KG
2LR
2P1
2VQ
2~H
30V
3O-
3V.
4.4
406
408
409
40D
40E
53G
5RE
5VS
67Z
6NX
7RV
7X7
88E
8AO
8C1
8FE
8FG
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AABQG
AAFGU
AAHNG
AAIAL
AAJKR
AANXM
AANZL
AAPBV
AARHV
AARTL
AATNV
AATVU
AAUYE
AAWCG
AAWTL
AAYFA
AAYIU
AAYQN
AAYTO
ABBBX
ABBXA
ABDZT
ABECU
ABFGW
ABFTV
ABHLI
ABHQN
ABIPD
ABJOX
ABKAS
ABKCH
ABKTR
ABLJU
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACBMV
ACBRV
ACBXY
ACBYP
ACGFS
ACHSB
ACHXU
ACIGE
ACIPQ
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACTTH
ACVWB
ACWMK
ADBBV
ADHHG
ADHIR
ADINQ
ADJJI
ADKNI
ADKPE
ADMDM
ADOXG
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFTE
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AENEX
AEOHA
AEPYU
AESKC
AESTI
AETLH
AEVLU
AEVTX
AEXYK
AFKRA
AFLOW
AFNRJ
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGBP
AGJBK
AGMZJ
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHMBA
AHSBF
AHYZX
AIAKS
AIIXL
AILAN
AIMYW
AITGF
AJBLW
AJDOV
AJRNO
AJZVZ
AKMHD
AKQUC
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARAPS
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BDATZ
BENPR
BGLVJ
BGNMA
BKEYQ
BMSDO
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIHBH
EIOEI
EJD
EN4
ESBYG
EX3
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GXS
H13
HCIFZ
HF~
HG5
HG6
HMJXF
HQYDN
HRMNR
HZ~
IHE
IJ-
IKXTQ
IMOTQ
IQODW
IWAJR
IXC
IXD
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KPH
LAS
LLZTM
M1P
M4Y
MA-
N2Q
N9A
NAPCQ
NB0
NPVJJ
NQJWS
NU0
O9-
O93
O9I
O9J
OAM
P62
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
Q2X
QOR
QOS
R89
R9I
RIG
ROL
RPX
RRX
RSV
S16
S1Z
S27
S37
S3B
SAP
SDH
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SZ9
SZN
T13
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UDS
UG4
UKHRP
UNUBA
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
WOW
X7J
YLTOR
Z45
Z7U
Z87
ZMTXR
ZOVNA
ZXP
AACDK
AAJBT
AASML
AAYZH
ABAKF
ABJNI
ACAOD
ACDTI
ACZOJ
AEFQL
AEMSY
AFBBN
AGQEE
AGRTI
AIGIU
ALIPV
CGR
CUY
CVF
ECM
EIF
EMB
EMOBN
HMCUK
HVGLF
NPM
SV3
AAYXX
CITATION
7XB
8FK
DWQXO
K9.
PQEST
PQUKI
PRINS
7X8
ID FETCH-LOGICAL-c253t-352c41a8d38df7c4f91e6c8055d0a3c9137022ee3a877d615a3c8e81dd586cc63
ISSN 0179-7158
IngestDate Fri Oct 25 05:46:39 EDT 2024
Mon Nov 04 10:36:54 EST 2024
Thu Nov 21 20:57:05 EST 2024
Wed Oct 16 00:41:23 EDT 2024
Sun Oct 29 17:08:02 EDT 2023
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Dose repartition
Human
Position
Size
Uterine cervix
Dimension
Malignant tumor
Radiotherapy
Female genital diseases
Geometry
Radiation dose
Applicator
Treatment
Pelvic cavity
Female
Technique
Curietherapy
Uterine cervix diseases
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c253t-352c41a8d38df7c4f91e6c8055d0a3c9137022ee3a877d615a3c8e81dd586cc63
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
PMID 9209530
PQID 821763140
PQPubID 54006
PageCount 7
ParticipantIDs proquest_miscellaneous_79112759
proquest_journals_821763140
crossref_primary_10_1007_BF03038915
pubmed_primary_9209530
pascalfrancis_primary_2701826
PublicationCentury 1900
PublicationDate 1997-Jun
PublicationDateYYYYMMDD 1997-06-01
PublicationDate_xml – month: 06
  year: 1997
  text: 1997-Jun
PublicationDecade 1990
PublicationPlace München
PublicationPlace_xml – name: München
– name: Germany
– name: Heidelberg
PublicationTitle Strahlentherapie und Onkologie
PublicationTitleAlternate Strahlenther Onkol
PublicationYear 1997
Publisher Springer
Springer Nature B.V
Publisher_xml – name: Springer
– name: Springer Nature B.V
References L. Krishnan (BF03038915_CR13) 1990; 18
G. S. Montana (BF03038915_CR16) 1989; 16
A. Arican (BF03038915_CR1) 1994; 31
B. M. Peckham (BF03038915_CR18) 1969; 104
H. Pourquier (BF03038915_CR22) 1982; 8
M. Tod (BF03038915_CR26) 1953; 26
T. Teschima (BF03038915_CR25) 1985; 161
D. A. Jones (BF03038915_CR11) 1987; 60
B. Corn (BF03038915_CR2) 1991; 21
R. A. Potish (BF03038915_CR20) 1990; 18
B. A. Esche (BF03038915_CR6) 1987; 13
J. M. Wilkinson (BF03038915_CR29) 1983; 56
A. Górny (BF03038915_CR7) 1992; 63
A. Eisbruch (BF03038915_CR5) 1990; 25
J. M. Crook (BF03038915_CR3) 1987; 8
K. H. Lee (BF03038915_CR14) 1976; 49
C. G. Orton (BF03038915_CR17) 1986; 12
A. D. Hamberger (BF03038915_CR9) 1983; 9
P. W. Grigsby (BF03038915_CR8) 1993; 27
R. R. Million (BF03038915_CR15) 1966; 60
ICRU Report 38 (BF03038915_CR10) 1985
E. Sherrah-Davies (BF03038915_CR23) 1985; 36
H. Pourquier (BF03038915_CR21) 1997; 13
C. C. Wang (BF03038915_CR28) 1981; 48
J. M. Wilkinson (BF03038915_CR30) 1989; 62
D. E. Cunningham (BF03038915_CR4) 1981; 7
J. A. Stryker (BF03038915_CR24) 1988; 29
A. Unal (BF03038915_CR27) 1981; 7
(BF03038915_CR19) 1990
A. R. Kagan (BF03038915_CR12) 1976; 4
References_xml – volume: 49
  start-page: 430
  year: 1976
  ident: BF03038915_CR14
  publication-title: Brit. J. Radiol.
  doi: 10.1259/0007-1285-49-581-430
  contributor:
    fullname: K. H. Lee
– volume: 4
  start-page: 291
  year: 1976
  ident: BF03038915_CR12
  publication-title: Gynec. Oncol.
  doi: 10.1016/0090-8258(76)90034-2
  contributor:
    fullname: A. R. Kagan
– volume: 18
  start-page: 965
  year: 1990
  ident: BF03038915_CR13
  publication-title: Int. J. Radiat. Oncol. Biol. Phys.
  doi: 10.1016/0360-3016(90)90424-I
  contributor:
    fullname: L. Krishnan
– volume: 16
  start-page: 95
  year: 1989
  ident: BF03038915_CR16
  publication-title: Int. J. Radiat. Oncol. Biol. Phys.
  doi: 10.1016/0360-3016(89)90015-1
  contributor:
    fullname: G. S. Montana
– volume: 26
  start-page: 252
  year: 1953
  ident: BF03038915_CR26
  publication-title: Brit. J. Radiol.
  doi: 10.1259/0007-1285-26-305-252
  contributor:
    fullname: M. Tod
– volume: 18
  start-page: 1513
  year: 1990
  ident: BF03038915_CR20
  publication-title: Int. J. Radiat. Oncol. Biol. Phys.
  doi: 10.1016/0360-3016(90)90329-I
  contributor:
    fullname: R. A. Potish
– volume: 48
  start-page: 538
  year: 1981
  ident: BF03038915_CR28
  publication-title: Cancer
  doi: 10.1002/1097-0142(19810715)48:1+<538::AID-CNCR2820481317>3.0.CO;2-P
  contributor:
    fullname: C. C. Wang
– volume: 104
  start-page: 485
  year: 1969
  ident: BF03038915_CR18
  publication-title: Amer. J. Obstet. Gynec.
  doi: 10.1016/S0002-9378(16)34236-3
  contributor:
    fullname: B. M. Peckham
– volume: 31
  start-page: 28
  issue: Suppl. 1
  year: 1994
  ident: BF03038915_CR1
  publication-title: Radiother. Oncol.
  doi: 10.1016/0167-8140(94)91126-6
  contributor:
    fullname: A. Arican
– volume: 25
  start-page: 733
  year: 1990
  ident: BF03038915_CR5
  publication-title: Int. J. Radiat. Oncol. Biol. Phys.
  doi: 10.1016/0360-3016(93)90022-N
  contributor:
    fullname: A. Eisbruch
– volume: 21
  start-page: 195
  issue: Suppl. 1
  year: 1991
  ident: BF03038915_CR2
  publication-title: Int. J. Radiat. Oncol. Biol. Phys.
  contributor:
    fullname: B. Corn
– volume: 13
  start-page: 1025
  year: 1997
  ident: BF03038915_CR21
  publication-title: Int. J. Radiat. Oncol. Biol. Phys.
  doi: 10.1016/0360-3016(87)90041-1
  contributor:
    fullname: H. Pourquier
– volume: 161
  start-page: 343
  year: 1985
  ident: BF03038915_CR25
  publication-title: Strahlentherapie
  contributor:
    fullname: T. Teschima
– volume: 63
  start-page: 8
  year: 1992
  ident: BF03038915_CR7
  publication-title: Gin. Pol.
  contributor:
    fullname: A. Górny
– volume: 9
  start-page: 367
  year: 1983
  ident: BF03038915_CR9
  publication-title: Int. J. Radiat. Oncol. Biol. Phys.
  doi: 10.1016/0360-3016(83)90298-5
  contributor:
    fullname: A. D. Hamberger
– volume: 60
  start-page: 921
  year: 1966
  ident: BF03038915_CR15
  publication-title: Radiology
  doi: 10.1148/86.5.921
  contributor:
    fullname: R. R. Million
– volume: 29
  start-page: 1
  year: 1988
  ident: BF03038915_CR24
  publication-title: Gynec. Oncol.
  doi: 10.1016/0090-8258(88)90140-0
  contributor:
    fullname: J. A. Stryker
– volume: 56
  start-page: 409
  year: 1983
  ident: BF03038915_CR29
  publication-title: Brit. J. Radiol.
  doi: 10.1259/0007-1285-56-666-409
  contributor:
    fullname: J. M. Wilkinson
– volume-title: Dose and volume specification for reporting intracavitary therapy in gynecology
  year: 1985
  ident: BF03038915_CR10
  contributor:
    fullname: ICRU Report 38
– volume: 8
  start-page: 1887
  year: 1982
  ident: BF03038915_CR22
  publication-title: Int. J. Radiat. Oncol. Biol. Phys.
  doi: 10.1016/0360-3016(82)90446-1
  contributor:
    fullname: H. Pourquier
– volume: 60
  start-page: 481
  year: 1987
  ident: BF03038915_CR11
  publication-title: Brit. J. Radiol.
  doi: 10.1259/0007-1285-60-713-481
  contributor:
    fullname: D. A. Jones
– volume: 62
  start-page: 362
  year: 1989
  ident: BF03038915_CR30
  publication-title: Brit. J. Radiol.
  doi: 10.1259/0007-1285-62-736-362
  contributor:
    fullname: J. M. Wilkinson
– volume-title: Annual Report on the results of treatment in gynecological cancer
  year: 1990
  ident: BF03038915_CR19
– volume: 7
  start-page: 999
  year: 1981
  ident: BF03038915_CR27
  publication-title: Int. J. Radiat. Oncol. Biol. Phys.
  doi: 10.1016/0360-3016(81)90150-4
  contributor:
    fullname: A. Unal
– volume: 36
  start-page: 131
  year: 1985
  ident: BF03038915_CR23
  publication-title: Clin. Radiol.
  doi: 10.1016/S0009-9260(85)80095-7
  contributor:
    fullname: E. Sherrah-Davies
– volume: 12
  start-page: 37
  year: 1986
  ident: BF03038915_CR17
  publication-title: Int. J. Radiat. Oncol. Biol. Phys.
  doi: 10.1016/0360-3016(86)90413-X
  contributor:
    fullname: C. G. Orton
– volume: 7
  start-page: 653
  year: 1981
  ident: BF03038915_CR4
  publication-title: Int. J. Radiat. Oncol. Biol. Phys.
  doi: 10.1016/0360-3016(81)90381-3
  contributor:
    fullname: D. E. Cunningham
– volume: 27
  start-page: 725
  year: 1993
  ident: BF03038915_CR8
  publication-title: Int. J. Radiat. Oncol. Biol. Phys.
  doi: 10.1016/0360-3016(93)90402-H
  contributor:
    fullname: P. W. Grigsby
– volume: 8
  start-page: 321
  year: 1987
  ident: BF03038915_CR3
  publication-title: Radiother. Oncol.
  doi: 10.1016/S0167-8140(87)80182-2
  contributor:
    fullname: J. M. Crook
– volume: 13
  start-page: 1183
  year: 1987
  ident: BF03038915_CR6
  publication-title: Int. J. Radiat. Oncol. Biol. Phys.
  doi: 10.1016/0360-3016(87)90193-3
  contributor:
    fullname: B. A. Esche
SSID ssj0016494
Score 1.5328166
Snippet Although the relationship between the dose delivered to adjacent organs (urinary bladder and rectum) and the frequency and severity of treatment complications...
AimAlthough the relationship between the dose delivered to adjacent organs (urinary bladder and rectum) and the frequency and severity of treatment...
AIMAlthough the relationship between the dose delivered to adjacent organs (urinary bladder and rectum) and the frequency and severity of treatment...
SourceID proquest
crossref
pubmed
pascalfrancis
SourceType Aggregation Database
Index Database
StartPage 323
SubjectTerms Anesthesia
Biological and medical sciences
Bladder
Brachytherapy - instrumentation
Cancer
Cervical cancer
Female
Humans
Linear Models
Medical sciences
Multivariate analysis
Optimization
Organs
Pellets
Radiation Dosage
Radiation therapy
Radiotherapy Dosage
Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)
Rectum
Rectum - radiation effects
Retrospective Studies
Technology. Biomaterials. Equipments. Material. Instrumentation
Urinary Bladder - radiation effects
Uterine Cervical Neoplasms - radiotherapy
Title Influence of brachytherapy applicators geometry on dose distribution in cervical cancer
URI https://www.ncbi.nlm.nih.gov/pubmed/9209530
https://www.proquest.com/docview/821763140
https://search.proquest.com/docview/79112759
Volume 173
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fa9swEBZZC2Mwyn6VeV03wfYWPGzLtuzHsKSky9YN0rH0ydiSvAZTu8TJQ__73lmWHcM2toe9hCAHJei-nL67k74j5L3EYk_mZXbMBbP91HXtFG8s5xFjzM9hx-Z4OXm-5BeraDrzZ6OR6ZrRj_1XS8MY2Bpvzv6DtbtJYQDeg83hFawOr39l93PTdQRpIITC4vpO37G6G5tiNfbX-amqG7XF-no5lnhmXaKCbtv8CpMgonEiqB6CuNjsk1hUtL3G3aqZd62wl-74a1k0frQDylKVxa62F1Wp8iIdXHpYVBl24C7SQTL1E_B4dTMsValNsdaObNHnJ7S2a7ifnzD5STx8jSWR7v6MTmfy2OauFm__oLQLBopkA29dDXy07nfSgjH8pe93-hPtWHwN-h3OVPXnk2XybXqWfD6_WAyfNhs6UKUQwsMYdQkOPXBc4DcPJ6urq2lXlwr9WKvFt797KHjbfvGA4jy-TWswVq7bpPw-jmn4zOUTctQGInSiEfSUjFT5jDz80h61eE5-dECiVU4HQKJ7QKIGSLQqKQKJ7gOJrktqgEQ1kF6Q72ezy49zu-3CYQsvYFsbGLrw3TSSLJI5F34euyoUkRME0kmZiF3GgQcqxdKIcwkEGQYjBWGQDKJQiJAdk4MSoPaSUCUDoJyRyLgK_IzBCnt-IFHEjvs5EE2LvDMLl9xqsZXEyGr3y2uR08Gadh_1uIPRskVOzBon7R-zTiIIvUPm-o5F3nZPwZNieSwtVbWrEw77vseD2CLH2jDdxLGHqozOqz9OfEIe9fB_TQ62m506JQ9quXvTougeqw-YxA
link.rule.ids 315,782,786,27933,27934
linkProvider Springer Nature
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Influence+of+brachytherapy+applicators+geometry+on+dose+distribution+in+cervical+cancer&rft.jtitle=Strahlentherapie+und+Onkologie&rft.au=Senkus-Konefka%2C+E&rft.au=Kobierska%2C+A&rft.au=Jassem%2C+J&rft.au=Serkies%2C+K&rft.date=1997-06-01&rft.pub=Springer+Nature+B.V&rft.issn=0179-7158&rft.eissn=1439-099X&rft.volume=173&rft.issue=6&rft_id=info:doi/10.1007%2FBF03038915&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=2226114921
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0179-7158&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0179-7158&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0179-7158&client=summon